Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

A comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening.

Bumann D, Holland P, Siejak F, Koesling J, Sabarth N, Lamer S, Zimny-Arndt U, Jungblut PR, Meyer TF.

Infect Immun. 2002 Nov;70(11):6494-8.

PMID:
12379736
2.

Protection against Helicobacter pylori infection by intestinal immunisation with a 50/52-kDa subunit protein.

Dunkley ML, Harris SJ, McCoy RJ, Musicka MJ, Eyers FM, Beagley LG, Lumley PJ, Beagley KW, Clancy RL.

FEMS Immunol Med Microbiol. 1999 Jun;24(2):221-5.

PMID:
10378424
3.

Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with high protective efficacy.

Sabarth N, Hurwitz R, Meyer TF, Bumann D.

Infect Immun. 2002 Nov;70(11):6499-503.

PMID:
12379737
4.

Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.

Hatzifoti C, Roussel Y, Harris AG, Wren BW, Morrow JW, Bajaj-Elliott M.

Helicobacter. 2006 Apr;11(2):113-22.

PMID:
16579841
5.

Catalase, a novel antigen for Helicobacter pylori vaccination.

Radcliff FJ, Hazell SL, Kolesnikow T, Doidge C, Lee A.

Infect Immun. 1997 Nov;65(11):4668-74.

PMID:
9353048
6.

Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model.

Hoffelner H, Rieder G, Haas R.

Int J Med Microbiol. 2008 Jan;298(1-2):151-9. Epub 2007 Aug 21. Review.

PMID:
17714988
7.

Effects of vaccination by a recombinant antigen ureB138 (a segment of the beta-subunit of urease) against Helicobacter pylori infection.

Morihara F, Fujii R, Hifumi E, Nishizono A, Uda T.

J Med Microbiol. 2007 Jun;56(Pt 6):847-53.

PMID:
17510273
8.

The current status of Helicobacter pylori vaccines: a review.

Kabir S.

Helicobacter. 2007 Apr;12(2):89-102. Review.

PMID:
17309745
9.

[Vaccines under development: Helicobacter pylori].

Harris D P, Serrano H C, Venegas E A.

Rev Chilena Infectol. 2006 Sep;23(3):249-56. Epub 2006 Aug 4. Spanish.

PMID:
16896500
10.

[A vaccine against Helicobacter pylori infection].

Presecki V, Katicić M, Kalenić S, Strnad M, Plecko V, Babus V, Dominis M.

Lijec Vjesn. 2002 Sep;124 Suppl 1:79-82. Polish.

PMID:
12592824
11.

Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection.

Anderson KM, Czinn SJ, Redline RW, Blanchard TG.

J Immunol. 2006 May 1;176(9):5306-13.

PMID:
16621997
12.

Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens.

Keenan JI, Rijpkema SG, Durrani Z, Roake JA.

FEMS Immunol Med Microbiol. 2003 May 25;36(3):199-205.

PMID:
12738392
13.

Helicobacter pylori flagella: antigenic profile and protective immunity.

Skene C, Young A, Every A, Sutton P.

FEMS Immunol Med Microbiol. 2007 Jul;50(2):249-56. Epub 2007 May 23.

PMID:
17521391
14.

Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy.

Rossi G, Ruggiero P, Peppoloni S, Pancotto L, Fortuna D, Lauretti L, Volpini G, Mancianti S, Corazza M, Taccini E, Di Pisa F, Rappuoli R, Del Giudice G.

Infect Immun. 2004 Jun;72(6):3252-9.

PMID:
15155627
15.

Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination.

Prinz C, Hafsi N, Voland P.

Trends Microbiol. 2003 Mar;11(3):134-8. Review.

PMID:
12648945
16.

[What's new in anti-Helicobacter pylori vaccination?].

Corthesy-Theulaz I, Michetti P.

Gastroenterol Clin Biol. 2000 Dec;24(12):1186-90. Review. English, French. No abstract available.

PMID:
11173731
17.

-Development of a mouse model for Helicobacter pylori infection in the human--progress toward vaccination against ulcer disease?-.

Gallwitz B, Schmidt WE.

Z Gastroenterol. 1996 Mar;34(3):202-4. German. No abstract available.

PMID:
8650975
18.

Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.

Sutton P, Doidge C, Pinczower G, Wilson J, Harbour S, Swierczak A, Lee A.

FEMS Immunol Med Microbiol. 2007 Jul;50(2):213-9.

PMID:
17567282
19.

Identification of genome-derived vaccine candidates conserved between human and mouse-adapted strains of H. pylori.

Moise L, McMurry JA, Pappo J, Lee DS, Moss SF, Martin WD, De Groot AS.

Hum Vaccin. 2008 May-Jun;4(3):219-23. Epub 2010 May 8.

PMID:
18376134
20.

Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.

Inoue K, Shiota S, Yamada K, Gotoh K, Suganuma M, Fujioka T, Ahmed K, Iha H, Nishizono A.

Helicobacter. 2009 Oct;14(5):135-43. doi: 10.1111/j.1523-5378.2009.00713.x.

PMID:
19751439

Supplemental Content

Support Center